These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20070854)

  • 1. Involvement of ERK1/2, p38 and PI3K in megakaryocytic differentiation of K562 cells.
    Conde I; Pabón D; Jayo A; Lastres P; González-Manchón C
    Eur J Haematol; 2010 May; 84(5):430-40. PubMed ID: 20070854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane type sialidase inhibits the megakaryocytic differentiation of human leukemia K562 cells.
    Jin UH; Ha KT; Kim KW; Chang YC; Lee YC; Ko JH; Kim CH
    Biochim Biophys Acta; 2008 May; 1780(5):757-63. PubMed ID: 18339327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis.
    Jacquel A; Herrant M; Defamie V; Belhacene N; Colosetti P; Marchetti S; Legros L; Deckert M; Mari B; Cassuto JP; Hofman P; Auberger P
    Oncogene; 2006 Feb; 25(5):781-94. PubMed ID: 16186797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-arginine methyltransferase 1 suppresses megakaryocytic differentiation via modulation of the p38 MAPK pathway in K562 cells.
    Chang YI; Hua WK; Yao CL; Hwang SM; Hung YC; Kuan CJ; Leou JS; Lin WJ
    J Biol Chem; 2010 Jul; 285(27):20595-606. PubMed ID: 20442406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK1/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5'-triphosphate-mediated terminal erythroid differentiation of K562 cells.
    Moosavi MA; Yazdanparast R; Lotfi A
    Int J Biochem Cell Biol; 2007; 39(9):1685-97. PubMed ID: 17543571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of PI3K, ERK, and p38 Signaling Pathways in the Production of Humoral Erythropoiesis Regulators under Normal Conditions.
    Dygai AM; Zhdanov VV; Miroshnichenko LA; Udut EV; Zyuz'kov GN; Khrichkova TY; Simanina EV; Sherstoboev EY; Stavrova LA; Chaikovskii AV; Burmina YV; Agafonov VI; Reikhart DV
    Bull Exp Biol Med; 2015 Nov; 160(1):17-9. PubMed ID: 26601839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibronectin- and protein kinase C-mediated activation of ERK/MAPK are essential for proplateletlike formation.
    Jiang F; Jia Y; Cohen I
    Blood; 2002 May; 99(10):3579-84. PubMed ID: 11986211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular signal-regulated kinase/90-KDA ribosomal S6 kinase/nuclear factor-kappa B pathway mediates phorbol 12-myristate 13-acetate-induced megakaryocytic differentiation of K562 cells.
    Kim KW; Kim SH; Lee EY; Kim ND; Kang HS; Kim HD; Chung BS; Kang CD
    J Biol Chem; 2001 Apr; 276(16):13186-91. PubMed ID: 11278385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactosylceramide alpha2,3-sialyltransferase is induced via a PKC/ERK/CREB-dependent pathway in K562 human leukemia cells.
    Choi HJ; Park YG; Kim CH
    Mol Cells; 2007 Apr; 23(2):138-44. PubMed ID: 17464189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humanin delays apoptosis in K562 cells by downregulation of P38 MAP kinase.
    Wang D; Li H; Yuan H; Zheng M; Bai C; Chen L; Pei X
    Apoptosis; 2005 Oct; 10(5):963-71. PubMed ID: 16151632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of nPKC-MAPK pathway in the decrease of nucleophosmin/B23 during megakaryocytic differentiation of human myelogenous leukemia K562 cells.
    Chou CC; Yung BY; Hsu CY
    Life Sci; 2007 May; 80(22):2051-9. PubMed ID: 17448503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro.
    Ono M; Matsubara Y; Shibano T; Ikeda Y; Murata M
    Platelets; 2011; 22(3):196-203. PubMed ID: 21231855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
    Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW
    Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinacrine induces apoptosis in human leukemia K562 cells via p38 MAPK-elicited BCL2 down-regulation and suppression of ERK/c-Jun-mediated BCL2L1 expression.
    Changchien JJ; Chen YJ; Huang CH; Cheng TL; Lin SR; Chang LS
    Toxicol Appl Pharmacol; 2015 Apr; 284(1):33-41. PubMed ID: 25684043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K562 cells resistant to phorbol 12-myristate 13-acetate-induced growth arrest: dissociation of mitogen-activated protein kinase activation and Egr-1 expression from megakaryocyte differentiation.
    Shelly C; Petruzzelli L; Herrera R
    Cell Growth Differ; 2000 Sep; 11(9):501-6. PubMed ID: 11007455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy is an important event for megakaryocytic differentiation of the chronic myelogenous leukemia K562 cell line.
    Colosetti P; Puissant A; Robert G; Luciano F; Jacquel A; Gounon P; Cassuto JP; Auberger P
    Autophagy; 2009 Nov; 5(8):1092-8. PubMed ID: 19786835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinases.
    Reimer RA
    J Endocrinol; 2006 Oct; 191(1):159-70. PubMed ID: 17065399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanical stimulation and mitogen-activated protein kinase signaling independently regulate osteogenic differentiation and mineralization by calcifying vascular cells.
    Simmons CA; Nikolovski J; Thornton AJ; Matlis S; Mooney DJ
    J Biomech; 2004 Oct; 37(10):1531-41. PubMed ID: 15336928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K562 cells.
    Herrera R; Hubbell S; Decker S; Petruzzelli L
    Exp Cell Res; 1998 Feb; 238(2):407-14. PubMed ID: 9473349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of PI3K, MAPK ERK1/2, and p38 in the realization of growth potential of mesenchymal precursor cells under in vitro conditions.
    Zyuz'kov GN; Danilets MG; Ligacheva AA; Zhdanov VV; Udut EV; Miroshnichenko LA; Simanina EV; Trofimova ES; Minakova MY; Chaikovskii AV; Agafonov VI; Dygai AM
    Bull Exp Biol Med; 2014 Feb; 156(4):556-9. PubMed ID: 24771448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.